Raphael Mechoulam, the Israeli organic chemist regarded as the father of cannabis science, announced a new discovery at the CannaMed conference in Pasadena.
NBC reports:
“They have developed a process for creating synthetic, stable acids that are found within the plant, and that the synthetic acids, which include acid versions of CBD and THC, are now available for licensing to companies for drug development.
“The discovery paves the way for drug companies to potentially develop new drugs based on the acids for a variety of health issues such as psoriasis, arthritis, anxiety and inflammatory bowel disease.”
The research was produced by a start up called EPM.